At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Autologous Protein Solution "APS(TM)"device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Single-Center Clinical Study of a Single Intra-Articular Injection of Autologous Protein Solution ("APS(TM)") in Patients With Osteoarthritis (OA) of the Knee
In Brief
A clinical study evaluating Autologous Protein Solution "APS(TM)" for Gonarthrosis and 2 related conditions. Completed, enrolled 11 participants across 1 site.
Detailed Summary
This prospective single-center study will evaluate the safety and tolerability of a single dose of "APS(TM)" treated patients with OA of the knee who have failed conservative OA therapy. The study will also evaluate efficacy by assessing patient pain and functionality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGonarthrosis, Knee Osteoarthritis, Osteoarthritis
CountriesNetherlands
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 2013
Enrollment StartMar 2013
Primary CompletionJun 2014
TodayJul 2026
First PostedJan 23, 2013
Enrollment StartMar 1, 2013
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 13.4 years ago
Interventions
Autologous Protein Solution "APS(TM)"device
A therapy prepared at the point-of-care from a small sample of the patient's own blood containing high concentrations of anti-inflammatory and anabolic proteins